CN Stock MarketDetailed Quotes

Jiangsu Chinagreen Biological Technology Group (300970)

Watchlist
  • 31.34
  • -1.46-4.45%
Market Closed May 21 15:00 CST
3.84BMarket Cap17.58P/E (TTM)

Jiangsu Chinagreen Biological Technology Group (300970) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
86.15%694.95M
63.40%590.12M
43.13%482.15M
11.23%351.59M
10.81%373.32M
-11.91%361.14M
-30.84%336.85M
-42.54%316.09M
-46.16%336.9M
-5.03%409.95M
Notes receivable and accounts receivable
3.46%20.7M
-17.06%13.85M
-1.26%19.25M
-4.15%15.79M
0.18%20M
-10.64%16.7M
17.12%19.49M
5.81%16.47M
31.05%19.97M
49.94%18.69M
-Accounts receivable
3.46%20.7M
-17.06%13.85M
-1.26%19.25M
-4.15%15.79M
0.18%20M
-10.64%16.7M
17.12%19.49M
5.81%16.47M
31.05%19.97M
49.94%18.69M
Other receivables (including interest and dividends)
-33.22%1.41M
15.67%2.19M
-34.25%2.32M
-39.54%1.87M
-42.74%2.12M
-46.29%1.89M
-19.45%3.53M
-3.35%3.1M
32.88%3.7M
69.48%3.52M
-Accrued interest receivable
----
----
----
----
----
----
-23.13%1.23M
-11.43%1.06M
83.93%1.24M
470.48%1.55M
-Other receivable
----
15.67%2.19M
----
-7.96%1.87M
----
-3.95%1.89M
----
1.49%2.04M
----
9.05%1.97M
Advance payment
12.78%3.47M
-19.65%2.1M
-49.53%3.24M
-56.22%3.96M
-32.36%3.08M
-57.58%2.61M
-40.29%6.42M
26.52%9.05M
-0.51%4.55M
22.29%6.15M
Inventories
14.74%232.5M
14.75%225M
6.97%206.99M
11.63%202.48M
13.57%202.63M
4.18%196.07M
1.98%193.5M
4.36%181.39M
9.18%178.41M
19.81%188.2M
Other current assets
9.31%1.11M
-11.04%1.4M
-5.50%1.85M
21.93%1.06M
5.96%1.01M
17.00%1.57M
0.28%1.96M
-16.11%867.17K
-10.71%956.26K
14.75%1.34M
Total current assets
58.45%954.14M
43.91%834.64M
27.42%715.8M
9.45%576.75M
10.59%602.16M
-7.63%579.98M
-20.94%561.75M
-29.82%526.96M
-34.62%544.48M
-11.53%627.85M
Non Current assets
Other equity investment
-0.24%320.3K
-35.66%212.54K
-57.62%166.88K
-40.55%235.53K
-40.16%321.06K
-34.44%330.34K
-18.28%393.81K
29.47%396.18K
42.57%536.52K
15.00%503.88K
Fixed assets
----
2.36%1.4B
----
16.18%1.36B
----
11.35%1.36B
----
8.16%1.17B
----
39.06%1.23B
Constru in process
----
-79.78%19.26M
----
-67.86%64.4M
----
1.86%95.3M
----
35.52%200.38M
----
-67.92%93.56M
Intangible assets
-3.22%55.7M
-3.19%56.16M
-1.08%56.63M
-1.02%57.09M
-0.96%57.55M
-0.90%58.02M
-1.02%57.25M
10.20%57.68M
12.50%58.11M
13.96%58.55M
Long deferred expense
----
----
--0
-90.70%12.5K
-87.54%25K
-86.05%37.5K
-79.48%69.14K
-66.81%134.46K
-56.10%200.72K
-48.83%268.86K
Usufruct assets
-28.87%123.78M
-15.66%153.81M
-26.04%157.28M
106.36%165.64M
102.96%174.01M
100.88%182.38M
3,501.75%212.66M
1,231.38%80.27M
1,220.27%85.74M
1,205.99%90.79M
Other non current assets
-40.02%13.86M
-66.75%8.22M
-84.66%9.71M
-61.37%20.24M
-32.82%23.11M
13.30%24.73M
51.73%63.3M
-5.17%52.4M
-4.60%34.4M
-43.20%21.82M
Total non current assets
-6.65%1.59B
-5.27%1.63B
-5.79%1.64B
6.79%1.67B
13.21%1.71B
15.72%1.73B
25.55%1.74B
16.15%1.56B
15.28%1.51B
17.34%1.49B
Total assets
10.34%2.55B
7.10%2.47B
2.31%2.36B
7.46%2.25B
12.52%2.31B
8.80%2.31B
9.80%2.3B
-0.30%2.09B
-4.15%2.05B
7.00%2.12B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
-16.70%20.01M
-16.68%20.01M
----
----
Notes payable and accounts payable
7.92%79.17M
10.90%81.31M
7.23%76.7M
4.64%83.98M
0.87%73.36M
-6.64%73.31M
-11.00%71.53M
21.57%80.26M
29.40%72.73M
38.16%78.53M
-Accounts payable
7.92%79.17M
10.90%81.31M
7.23%76.7M
4.64%83.98M
0.87%73.36M
-6.64%73.31M
-11.00%71.53M
21.57%80.26M
29.40%72.73M
38.16%78.53M
Contract liabilities
--3.62M
-2.62%3.34M
-10.25%2.41M
-44.70%1.68M
----
-5.63%3.43M
-12.74%2.68M
-17.06%3.04M
----
-56.69%3.64M
Advance receipts
----
----
----
----
-14.80%2.44M
----
----
----
--2.87M
----
Salaries payable
10.89%30.68M
37.94%39.19M
13.55%28.87M
16.42%28.7M
15.28%27.66M
1.07%28.41M
24.14%25.42M
28.38%24.65M
30.63%24M
22.40%28.11M
Taxs payable
74.71%377.89K
21.17%418.43K
32.68%318.03K
-13.46%210.64K
3.38%216.3K
33.92%345.34K
-14.70%239.7K
-78.64%243.4K
-76.72%209.23K
-73.33%257.87K
Other payable (including interest and dividends)
-20.17%46.09M
-26.93%49.87M
-8.30%48.76M
-11.58%52.2M
13.31%57.73M
14.85%68.25M
-0.94%53.18M
81.57%59.03M
72.38%50.95M
74.56%59.42M
-Other payable
----
-26.93%49.87M
----
-11.58%52.2M
----
14.85%68.25M
----
81.57%59.03M
----
74.56%59.42M
Non current liabilities due within one year
45.28%70.83M
45.52%71.08M
340.94%25.82M
80.54%25.7M
15.84%48.75M
-23.47%48.85M
-93.61%5.86M
-84.74%14.24M
-13.33%42.09M
33.66%63.83M
Total current liabilities
9.80%230.75M
10.16%245.2M
2.22%182.88M
-4.47%192.47M
8.99%210.17M
-4.78%222.59M
-34.58%178.92M
-16.00%201.47M
6.36%192.84M
26.39%233.77M
Current liabilities
Long term loan
-8.18%287.48M
-8.00%278.71M
4.20%349.76M
26.07%328.72M
91.19%313.09M
77.77%302.94M
86.78%335.67M
36.82%260.75M
-32.98%163.76M
-24.91%170.41M
Estimate liabilities
776.90%2.36M
613.67%2.36M
--0
----
--269.02K
--330.55K
----
----
----
----
Long term deferred income
7.57%46.91M
7.68%49.38M
--51.9M
-2.89%42.16M
--43.61M
-3.97%45.85M
----
-3.43%43.42M
----
6.07%47.75M
Lease liabilities
-12.50%189.04M
3.42%221.75M
--215.03M
116.06%217.51M
--216.04M
116.36%214.41M
----
22,107.36%100.67M
----
10,780.94%99.1M
Other non current liabilities
----
----
----
----
----
----
12.26%48.19M
----
--45.58M
----
Total non current liabilities
-8.24%525.8M
-2.01%552.2M
-0.88%616.68M
45.34%588.39M
85.30%573.01M
77.63%563.54M
179.21%622.13M
71.55%404.84M
5.87%309.23M
16.27%317.26M
Total liabilities
-3.40%756.55M
1.43%797.4M
-0.18%799.57M
28.79%780.86M
55.99%783.18M
42.66%786.12M
61.40%801.04M
27.42%606.32M
6.06%502.07M
20.36%551.03M
Shareholders equity
Paid-in capital
2.00%122.61M
2.00%122.61M
3.02%121.45M
1.96%120.2M
1.96%120.2M
1.96%120.2M
1.02%117.89M
1.02%117.89M
1.02%117.89M
1.02%117.89M
Capital reserve funds
2.99%946.02M
3.52%947.96M
5.13%936.44M
4.07%921.34M
4.47%918.55M
4.90%915.76M
4.12%890.71M
4.91%885.33M
4.18%879.22M
3.45%873.01M
Surplus reserve funds
0.00%48.37M
0.00%48.37M
120.09%48.37M
120.09%48.37M
120.09%48.37M
120.09%48.37M
0.00%21.98M
0.00%21.98M
0.00%21.98M
0.00%21.98M
Retained profit
49.77%657.87M
25.19%547.98M
-4.73%454.04M
-17.74%384.02M
-18.13%439.26M
-18.15%437.71M
-17.86%476.58M
-23.66%466.84M
-18.44%536.51M
1.33%534.78M
Less:Treasury stock
0.00%30.01M
0.00%30.01M
0.00%30.01M
0.00%30.01M
0.00%30.01M
--30.01M
--30.01M
--30.01M
--30.01M
----
Shareholders equity without minority interests
16.61%1.74B
9.71%1.64B
3.60%1.53B
-1.24%1.44B
-1.92%1.5B
-3.59%1.49B
-6.18%1.48B
-8.29%1.46B
-7.00%1.53B
2.47%1.55B
Minority interests
60.33%44.55M
27.78%34.97M
6.32%26.88M
-1.74%23.09M
20.72%27.79M
34.92%27.37M
-6.78%25.28M
-16.66%23.5M
-9.91%23.02M
66.74%20.29M
Total shareholder equity
17.40%1.79B
10.04%1.67B
3.64%1.56B
-1.25%1.47B
-1.58%1.52B
-3.10%1.52B
-6.19%1.5B
-8.43%1.49B
-7.05%1.55B
2.98%1.57B
Total liabilityies and equity
10.34%2.55B
7.10%2.47B
2.31%2.36B
7.46%2.25B
12.52%2.31B
8.80%2.31B
9.80%2.3B
-0.30%2.09B
-4.15%2.05B
7.00%2.12B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds 86.15%694.95M63.40%590.12M43.13%482.15M11.23%351.59M10.81%373.32M-11.91%361.14M-30.84%336.85M-42.54%316.09M-46.16%336.9M-5.03%409.95M
Notes receivable and accounts receivable 3.46%20.7M-17.06%13.85M-1.26%19.25M-4.15%15.79M0.18%20M-10.64%16.7M17.12%19.49M5.81%16.47M31.05%19.97M49.94%18.69M
-Accounts receivable 3.46%20.7M-17.06%13.85M-1.26%19.25M-4.15%15.79M0.18%20M-10.64%16.7M17.12%19.49M5.81%16.47M31.05%19.97M49.94%18.69M
Other receivables (including interest and dividends) -33.22%1.41M15.67%2.19M-34.25%2.32M-39.54%1.87M-42.74%2.12M-46.29%1.89M-19.45%3.53M-3.35%3.1M32.88%3.7M69.48%3.52M
-Accrued interest receivable -------------------------23.13%1.23M-11.43%1.06M83.93%1.24M470.48%1.55M
-Other receivable ----15.67%2.19M-----7.96%1.87M-----3.95%1.89M----1.49%2.04M----9.05%1.97M
Advance payment 12.78%3.47M-19.65%2.1M-49.53%3.24M-56.22%3.96M-32.36%3.08M-57.58%2.61M-40.29%6.42M26.52%9.05M-0.51%4.55M22.29%6.15M
Inventories 14.74%232.5M14.75%225M6.97%206.99M11.63%202.48M13.57%202.63M4.18%196.07M1.98%193.5M4.36%181.39M9.18%178.41M19.81%188.2M
Other current assets 9.31%1.11M-11.04%1.4M-5.50%1.85M21.93%1.06M5.96%1.01M17.00%1.57M0.28%1.96M-16.11%867.17K-10.71%956.26K14.75%1.34M
Total current assets 58.45%954.14M43.91%834.64M27.42%715.8M9.45%576.75M10.59%602.16M-7.63%579.98M-20.94%561.75M-29.82%526.96M-34.62%544.48M-11.53%627.85M
Non Current assets
Other equity investment -0.24%320.3K-35.66%212.54K-57.62%166.88K-40.55%235.53K-40.16%321.06K-34.44%330.34K-18.28%393.81K29.47%396.18K42.57%536.52K15.00%503.88K
Fixed assets ----2.36%1.4B----16.18%1.36B----11.35%1.36B----8.16%1.17B----39.06%1.23B
Constru in process -----79.78%19.26M-----67.86%64.4M----1.86%95.3M----35.52%200.38M-----67.92%93.56M
Intangible assets -3.22%55.7M-3.19%56.16M-1.08%56.63M-1.02%57.09M-0.96%57.55M-0.90%58.02M-1.02%57.25M10.20%57.68M12.50%58.11M13.96%58.55M
Long deferred expense ----------0-90.70%12.5K-87.54%25K-86.05%37.5K-79.48%69.14K-66.81%134.46K-56.10%200.72K-48.83%268.86K
Usufruct assets -28.87%123.78M-15.66%153.81M-26.04%157.28M106.36%165.64M102.96%174.01M100.88%182.38M3,501.75%212.66M1,231.38%80.27M1,220.27%85.74M1,205.99%90.79M
Other non current assets -40.02%13.86M-66.75%8.22M-84.66%9.71M-61.37%20.24M-32.82%23.11M13.30%24.73M51.73%63.3M-5.17%52.4M-4.60%34.4M-43.20%21.82M
Total non current assets -6.65%1.59B-5.27%1.63B-5.79%1.64B6.79%1.67B13.21%1.71B15.72%1.73B25.55%1.74B16.15%1.56B15.28%1.51B17.34%1.49B
Total assets 10.34%2.55B7.10%2.47B2.31%2.36B7.46%2.25B12.52%2.31B8.80%2.31B9.80%2.3B-0.30%2.09B-4.15%2.05B7.00%2.12B
Liabilities
Current liabilities
Short term loan -------------------------16.70%20.01M-16.68%20.01M--------
Notes payable and accounts payable 7.92%79.17M10.90%81.31M7.23%76.7M4.64%83.98M0.87%73.36M-6.64%73.31M-11.00%71.53M21.57%80.26M29.40%72.73M38.16%78.53M
-Accounts payable 7.92%79.17M10.90%81.31M7.23%76.7M4.64%83.98M0.87%73.36M-6.64%73.31M-11.00%71.53M21.57%80.26M29.40%72.73M38.16%78.53M
Contract liabilities --3.62M-2.62%3.34M-10.25%2.41M-44.70%1.68M-----5.63%3.43M-12.74%2.68M-17.06%3.04M-----56.69%3.64M
Advance receipts -----------------14.80%2.44M--------------2.87M----
Salaries payable 10.89%30.68M37.94%39.19M13.55%28.87M16.42%28.7M15.28%27.66M1.07%28.41M24.14%25.42M28.38%24.65M30.63%24M22.40%28.11M
Taxs payable 74.71%377.89K21.17%418.43K32.68%318.03K-13.46%210.64K3.38%216.3K33.92%345.34K-14.70%239.7K-78.64%243.4K-76.72%209.23K-73.33%257.87K
Other payable (including interest and dividends) -20.17%46.09M-26.93%49.87M-8.30%48.76M-11.58%52.2M13.31%57.73M14.85%68.25M-0.94%53.18M81.57%59.03M72.38%50.95M74.56%59.42M
-Other payable -----26.93%49.87M-----11.58%52.2M----14.85%68.25M----81.57%59.03M----74.56%59.42M
Non current liabilities due within one year 45.28%70.83M45.52%71.08M340.94%25.82M80.54%25.7M15.84%48.75M-23.47%48.85M-93.61%5.86M-84.74%14.24M-13.33%42.09M33.66%63.83M
Total current liabilities 9.80%230.75M10.16%245.2M2.22%182.88M-4.47%192.47M8.99%210.17M-4.78%222.59M-34.58%178.92M-16.00%201.47M6.36%192.84M26.39%233.77M
Current liabilities
Long term loan -8.18%287.48M-8.00%278.71M4.20%349.76M26.07%328.72M91.19%313.09M77.77%302.94M86.78%335.67M36.82%260.75M-32.98%163.76M-24.91%170.41M
Estimate liabilities 776.90%2.36M613.67%2.36M--0------269.02K--330.55K----------------
Long term deferred income 7.57%46.91M7.68%49.38M--51.9M-2.89%42.16M--43.61M-3.97%45.85M-----3.43%43.42M----6.07%47.75M
Lease liabilities -12.50%189.04M3.42%221.75M--215.03M116.06%217.51M--216.04M116.36%214.41M----22,107.36%100.67M----10,780.94%99.1M
Other non current liabilities ------------------------12.26%48.19M------45.58M----
Total non current liabilities -8.24%525.8M-2.01%552.2M-0.88%616.68M45.34%588.39M85.30%573.01M77.63%563.54M179.21%622.13M71.55%404.84M5.87%309.23M16.27%317.26M
Total liabilities -3.40%756.55M1.43%797.4M-0.18%799.57M28.79%780.86M55.99%783.18M42.66%786.12M61.40%801.04M27.42%606.32M6.06%502.07M20.36%551.03M
Shareholders equity
Paid-in capital 2.00%122.61M2.00%122.61M3.02%121.45M1.96%120.2M1.96%120.2M1.96%120.2M1.02%117.89M1.02%117.89M1.02%117.89M1.02%117.89M
Capital reserve funds 2.99%946.02M3.52%947.96M5.13%936.44M4.07%921.34M4.47%918.55M4.90%915.76M4.12%890.71M4.91%885.33M4.18%879.22M3.45%873.01M
Surplus reserve funds 0.00%48.37M0.00%48.37M120.09%48.37M120.09%48.37M120.09%48.37M120.09%48.37M0.00%21.98M0.00%21.98M0.00%21.98M0.00%21.98M
Retained profit 49.77%657.87M25.19%547.98M-4.73%454.04M-17.74%384.02M-18.13%439.26M-18.15%437.71M-17.86%476.58M-23.66%466.84M-18.44%536.51M1.33%534.78M
Less:Treasury stock 0.00%30.01M0.00%30.01M0.00%30.01M0.00%30.01M0.00%30.01M--30.01M--30.01M--30.01M--30.01M----
Shareholders equity without minority interests 16.61%1.74B9.71%1.64B3.60%1.53B-1.24%1.44B-1.92%1.5B-3.59%1.49B-6.18%1.48B-8.29%1.46B-7.00%1.53B2.47%1.55B
Minority interests 60.33%44.55M27.78%34.97M6.32%26.88M-1.74%23.09M20.72%27.79M34.92%27.37M-6.78%25.28M-16.66%23.5M-9.91%23.02M66.74%20.29M
Total shareholder equity 17.40%1.79B10.04%1.67B3.64%1.56B-1.25%1.47B-1.58%1.52B-3.10%1.52B-6.19%1.5B-8.43%1.49B-7.05%1.55B2.98%1.57B
Total liabilityies and equity 10.34%2.55B7.10%2.47B2.31%2.36B7.46%2.25B12.52%2.31B8.80%2.31B9.80%2.3B-0.30%2.09B-4.15%2.05B7.00%2.12B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PwC China (Special General Partnership)------PwC China (Special General Partnership)------PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More